SHR 1905
Alternative Names: AIO-001; SHR-1905Latest Information Update: 20 Dec 2023
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Developer Atridia; Shanghai Hengrui Pharmaceutical
- Class Anti-inflammatories; Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Thymic stromal lymphopoietin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Asthma; Rhinosinusitis